Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy of Cladribine versus Placebo in the reduction of qualifying relapse rate during 96 weeks of treatment in subjects with RRMS.
Inclusion criteria
- Relapsing-remitting multiple sclerosis (RRMS)